nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—IKBKB—Acetylsalicylic acid—Kawasaki disease	0.354	0.791	CbGbCtD
Mesalazine—Salicylate-sodium—Acetylsalicylic acid—Kawasaki disease	0.217	0.458	CrCrCtD
Mesalazine—Salicylamide—Acetylsalicylic acid—Kawasaki disease	0.132	0.279	CrCrCtD
Mesalazine—Salicylic acid—Acetylsalicylic acid—Kawasaki disease	0.124	0.263	CrCrCtD
Mesalazine—PTGS2—Acetylsalicylic acid—Kawasaki disease	0.0508	0.113	CbGbCtD
Mesalazine—PTGS1—Acetylsalicylic acid—Kawasaki disease	0.0429	0.0958	CbGbCtD
Mesalazine—Reye's syndrome—Acetylsalicylic acid—Kawasaki disease	0.0159	0.384	CcSEcCtD
Mesalazine—Breast feeding—Acetylsalicylic acid—Kawasaki disease	0.00273	0.0661	CcSEcCtD
Mesalazine—MPO—artery—Kawasaki disease	0.00214	0.0812	CbGeAlD
Mesalazine—PPARG—artery—Kawasaki disease	0.0019	0.072	CbGeAlD
Mesalazine—MPO—endothelium—Kawasaki disease	0.0018	0.0686	CbGeAlD
Mesalazine—Foetor hepaticus—Acetylsalicylic acid—Kawasaki disease	0.00168	0.0407	CcSEcCtD
Mesalazine—CHUK—heart—Kawasaki disease	0.00165	0.0627	CbGeAlD
Mesalazine—CHUK—skin of body—Kawasaki disease	0.00162	0.0614	CbGeAlD
Mesalazine—PPARG—endothelium—Kawasaki disease	0.0016	0.0608	CbGeAlD
Mesalazine—Liver disorder—Acetylsalicylic acid—Kawasaki disease	0.0014	0.0339	CcSEcCtD
Mesalazine—CHUK—NLR Proteins—CD40—Kawasaki disease	0.00126	0.111	CbGpPWpGaD
Mesalazine—Hepatotoxicity—Acetylsalicylic acid—Kawasaki disease	0.00124	0.0299	CcSEcCtD
Mesalazine—IKBKB—NLR Proteins—CD40—Kawasaki disease	0.00114	0.101	CbGpPWpGaD
Mesalazine—MPO—myocardium—Kawasaki disease	0.00113	0.0428	CbGeAlD
Mesalazine—IKBKB—heart—Kawasaki disease	0.00112	0.0426	CbGeAlD
Mesalazine—IKBKB—skin of body—Kawasaki disease	0.0011	0.0417	CbGeAlD
Mesalazine—PPARG—neck—Kawasaki disease	0.00106	0.0401	CbGeAlD
Mesalazine—Gout—Acetylsalicylic acid—Kawasaki disease	0.00102	0.0247	CcSEcCtD
Mesalazine—PTGS1—artery—Kawasaki disease	0.00101	0.0385	CbGeAlD
Mesalazine—PPARG—myocardium—Kawasaki disease	0.001	0.038	CbGeAlD
Mesalazine—PTGS2—artery—Kawasaki disease	0.000969	0.0368	CbGeAlD
Mesalazine—Hepatocellular injury—Acetylsalicylic acid—Kawasaki disease	0.000956	0.0231	CcSEcCtD
Mesalazine—Melaena—Acetylsalicylic acid—Kawasaki disease	0.000933	0.0226	CcSEcCtD
Mesalazine—ALOX5—heart—Kawasaki disease	0.00093	0.0353	CbGeAlD
Mesalazine—Coma—Acetylsalicylic acid—Kawasaki disease	0.000873	0.0211	CcSEcCtD
Mesalazine—PTGS1—endothelium—Kawasaki disease	0.000856	0.0325	CbGeAlD
Mesalazine—PTGS2—endothelium—Kawasaki disease	0.000818	0.0311	CbGeAlD
Mesalazine—MPO—heart—Kawasaki disease	0.000787	0.0299	CbGeAlD
Mesalazine—Deafness—Acetylsalicylic acid—Kawasaki disease	0.000775	0.0187	CcSEcCtD
Mesalazine—MPO—skin of body—Kawasaki disease	0.000771	0.0293	CbGeAlD
Mesalazine—Renal impairment—Acetylsalicylic acid—Kawasaki disease	0.000729	0.0176	CcSEcCtD
Mesalazine—Thirst—Acetylsalicylic acid—Kawasaki disease	0.000729	0.0176	CcSEcCtD
Mesalazine—PTGS2—gall bladder—Kawasaki disease	0.00071	0.027	CbGeAlD
Mesalazine—PPARG—heart—Kawasaki disease	0.000698	0.0265	CbGeAlD
Mesalazine—Gastrointestinal haemorrhage—Acetylsalicylic acid—Kawasaki disease	0.000694	0.0168	CcSEcCtD
Mesalazine—PPARG—skin of body—Kawasaki disease	0.000684	0.026	CbGeAlD
Mesalazine—Influenza—Acetylsalicylic acid—Kawasaki disease	0.000599	0.0145	CcSEcCtD
Mesalazine—Asthma—Acetylsalicylic acid—Kawasaki disease	0.000599	0.0145	CcSEcCtD
Mesalazine—PTGS1—myocardium—Kawasaki disease	0.000535	0.0203	CbGeAlD
Mesalazine—Sweating—Acetylsalicylic acid—Kawasaki disease	0.000512	0.0124	CcSEcCtD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—ITPKC—Kawasaki disease	0.000493	0.0434	CbGpPWpGaD
Mesalazine—Haemoglobin—Acetylsalicylic acid—Kawasaki disease	0.000482	0.0117	CcSEcCtD
Mesalazine—Haemorrhage—Acetylsalicylic acid—Kawasaki disease	0.00048	0.0116	CcSEcCtD
Mesalazine—Tinnitus—Acetylsalicylic acid—Kawasaki disease	0.000447	0.0108	CcSEcCtD
Mesalazine—Anaemia—Acetylsalicylic acid—Kawasaki disease	0.000386	0.00934	CcSEcCtD
Mesalazine—Angioedema—Acetylsalicylic acid—Kawasaki disease	0.000382	0.00923	CcSEcCtD
Mesalazine—Vertigo—Acetylsalicylic acid—Kawasaki disease	0.000375	0.00907	CcSEcCtD
Mesalazine—Syncope—Acetylsalicylic acid—Kawasaki disease	0.000375	0.00906	CcSEcCtD
Mesalazine—Leukopenia—Acetylsalicylic acid—Kawasaki disease	0.000374	0.00904	CcSEcCtD
Mesalazine—PTGS1—heart—Kawasaki disease	0.000373	0.0142	CbGeAlD
Mesalazine—MPO—Vitamin B12 Metabolism—CRP—Kawasaki disease	0.000369	0.0325	CbGpPWpGaD
Mesalazine—Loss of consciousness—Acetylsalicylic acid—Kawasaki disease	0.000367	0.00888	CcSEcCtD
Mesalazine—PTGS1—skin of body—Kawasaki disease	0.000366	0.0139	CbGeAlD
Mesalazine—Hypertension—Acetylsalicylic acid—Kawasaki disease	0.000361	0.00872	CcSEcCtD
Mesalazine—PTGS2—heart—Kawasaki disease	0.000357	0.0136	CbGeAlD
Mesalazine—Arthralgia—Acetylsalicylic acid—Kawasaki disease	0.000356	0.0086	CcSEcCtD
Mesalazine—Chest pain—Acetylsalicylic acid—Kawasaki disease	0.000356	0.0086	CcSEcCtD
Mesalazine—CHUK—Osteopontin Signaling—MMP9—Kawasaki disease	0.000356	0.0313	CbGpPWpGaD
Mesalazine—PTGS2—skin of body—Kawasaki disease	0.000349	0.0133	CbGeAlD
Mesalazine—Confusional state—Acetylsalicylic acid—Kawasaki disease	0.000344	0.00831	CcSEcCtD
Mesalazine—Anaphylactic shock—Acetylsalicylic acid—Kawasaki disease	0.000341	0.00824	CcSEcCtD
Mesalazine—Shock—Acetylsalicylic acid—Kawasaki disease	0.000335	0.00811	CcSEcCtD
Mesalazine—Thrombocytopenia—Acetylsalicylic acid—Kawasaki disease	0.000334	0.00807	CcSEcCtD
Mesalazine—PTGS1—Overview of nanoparticle effects—CRP—Kawasaki disease	0.000333	0.0293	CbGpPWpGaD
Mesalazine—Tachycardia—Acetylsalicylic acid—Kawasaki disease	0.000333	0.00805	CcSEcCtD
Mesalazine—Hyperhidrosis—Acetylsalicylic acid—Kawasaki disease	0.00033	0.00797	CcSEcCtD
Mesalazine—MPO—IL23-mediated signaling events—CD4—Kawasaki disease	0.000322	0.0284	CbGpPWpGaD
Mesalazine—IKBKB—Osteopontin Signaling—MMP9—Kawasaki disease	0.000322	0.0284	CbGpPWpGaD
Mesalazine—Dyspnoea—Acetylsalicylic acid—Kawasaki disease	0.000304	0.00735	CcSEcCtD
Mesalazine—Somnolence—Acetylsalicylic acid—Kawasaki disease	0.000303	0.00733	CcSEcCtD
Mesalazine—MPO—Folate Metabolism—CRP—Kawasaki disease	0.0003	0.0265	CbGpPWpGaD
Mesalazine—Dyspepsia—Acetylsalicylic acid—Kawasaki disease	0.0003	0.00726	CcSEcCtD
Mesalazine—Feeling abnormal—Acetylsalicylic acid—Kawasaki disease	0.000281	0.00679	CcSEcCtD
Mesalazine—Urticaria—Acetylsalicylic acid—Kawasaki disease	0.000271	0.00655	CcSEcCtD
Mesalazine—PTGS2—Overview of nanoparticle effects—CRP—Kawasaki disease	0.000264	0.0233	CbGpPWpGaD
Mesalazine—Hypersensitivity—Acetylsalicylic acid—Kawasaki disease	0.000251	0.00607	CcSEcCtD
Mesalazine—IKBKB—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—Kawasaki disease	0.000245	0.0216	CbGpPWpGaD
Mesalazine—Pruritus—Acetylsalicylic acid—Kawasaki disease	0.000241	0.00583	CcSEcCtD
Mesalazine—MPO—Selenium Micronutrient Network—CRP—Kawasaki disease	0.000239	0.021	CbGpPWpGaD
Mesalazine—Diarrhoea—Acetylsalicylic acid—Kawasaki disease	0.000233	0.00564	CcSEcCtD
Mesalazine—CHUK—B Cell Receptor Signaling Pathway—BLK—Kawasaki disease	0.000226	0.0199	CbGpPWpGaD
Mesalazine—Dizziness—Acetylsalicylic acid—Kawasaki disease	0.000225	0.00545	CcSEcCtD
Mesalazine—ALOX5—Selenium Micronutrient Network—CRP—Kawasaki disease	0.000225	0.0198	CbGpPWpGaD
Mesalazine—Vomiting—Acetylsalicylic acid—Kawasaki disease	0.000217	0.00524	CcSEcCtD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—BLK—Kawasaki disease	0.000216	0.019	CbGpPWpGaD
Mesalazine—Rash—Acetylsalicylic acid—Kawasaki disease	0.000215	0.0052	CcSEcCtD
Mesalazine—Dermatitis—Acetylsalicylic acid—Kawasaki disease	0.000215	0.00519	CcSEcCtD
Mesalazine—IKBKB—B Cell Receptor Signaling Pathway—BLK—Kawasaki disease	0.000205	0.0181	CbGpPWpGaD
Mesalazine—Nausea—Acetylsalicylic acid—Kawasaki disease	0.000202	0.0049	CcSEcCtD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—CD40—Kawasaki disease	0.00018	0.0159	CbGpPWpGaD
Mesalazine—CHUK—Osteopontin-mediated events—MMP9—Kawasaki disease	0.000177	0.0156	CbGpPWpGaD
Mesalazine—MPO—C-MYB transcription factor network—CD4—Kawasaki disease	0.000167	0.0147	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—CD40—Kawasaki disease	0.000164	0.0144	CbGpPWpGaD
Mesalazine—CHUK—Downstream TCR signaling—CD4—Kawasaki disease	0.000163	0.0144	CbGpPWpGaD
Mesalazine—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—Kawasaki disease	0.00016	0.0141	CbGpPWpGaD
Mesalazine—IKBKB—Downstream TCR signaling—CD4—Kawasaki disease	0.000148	0.013	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.000141	0.0124	CbGpPWpGaD
Mesalazine—PTGS2—S1P1 pathway—VEGFA—Kawasaki disease	0.00014	0.0123	CbGpPWpGaD
Mesalazine—CHUK—TWEAK Signaling Pathway—MMP9—Kawasaki disease	0.000139	0.0123	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—CCR5—Kawasaki disease	0.000138	0.0122	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ITPKC—Kawasaki disease	0.000131	0.0115	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—BLK—Kawasaki disease	0.000129	0.0114	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.000128	0.0113	CbGpPWpGaD
Mesalazine—IKBKB—TWEAK Signaling Pathway—MMP9—Kawasaki disease	0.000126	0.0111	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—CCR5—Kawasaki disease	0.000125	0.011	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling—CD4—Kawasaki disease	0.000122	0.0107	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—FCGR2A—Kawasaki disease	0.000118	0.0104	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—BLK—Kawasaki disease	0.000117	0.0103	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD4+ T cells—CD4—Kawasaki disease	0.000111	0.00981	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling—CD4—Kawasaki disease	0.00011	0.00973	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—Kawasaki disease	0.000101	0.00889	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—CRP—Kawasaki disease	9.77e-05	0.00861	CbGpPWpGaD
Mesalazine—CHUK—AGE/RAGE pathway—MMP9—Kawasaki disease	9.69e-05	0.00854	CbGpPWpGaD
Mesalazine—IKBKB—AGE/RAGE pathway—MMP9—Kawasaki disease	8.79e-05	0.00774	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—CD4—Kawasaki disease	8.68e-05	0.00765	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ITPKC—Kawasaki disease	8.09e-05	0.00713	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—CD4—Kawasaki disease	7.87e-05	0.00694	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—CRP—Kawasaki disease	7.75e-05	0.00683	CbGpPWpGaD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	6.88e-05	0.00606	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ITPKC—Kawasaki disease	5.67e-05	0.00499	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—FCGR2A—Kawasaki disease	5.6e-05	0.00493	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—CD4—Kawasaki disease	5.44e-05	0.00479	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—MMP9—Kawasaki disease	5.28e-05	0.00465	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—BLK—Kawasaki disease	5.21e-05	0.00459	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—FCGR2A—Kawasaki disease	5.08e-05	0.00447	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—BLK—Kawasaki disease	4.73e-05	0.00417	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ITPKC—Kawasaki disease	4.5e-05	0.00396	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	4.49e-05	0.00395	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD40—Kawasaki disease	4.33e-05	0.00382	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD40—Kawasaki disease	3.93e-05	0.00346	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	3.72e-05	0.00328	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—MMP9—Kawasaki disease	3.61e-05	0.00318	CbGpPWpGaD
Mesalazine—CHUK—Immune System—FCGR2A—Kawasaki disease	3.26e-05	0.00287	CbGpPWpGaD
Mesalazine—CHUK—Immune System—BLK—Kawasaki disease	3.16e-05	0.00279	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FCGR2A—Kawasaki disease	2.96e-05	0.00261	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CRP—Kawasaki disease	2.91e-05	0.00256	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—BLK—Kawasaki disease	2.87e-05	0.00253	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CRP—Kawasaki disease	2.64e-05	0.00232	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD40—Kawasaki disease	2.63e-05	0.00232	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD40—Kawasaki disease	2.38e-05	0.0021	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	2.2e-05	0.00194	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MMP9—Kawasaki disease	2.06e-05	0.00182	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CD4—Kawasaki disease	1.96e-05	0.00173	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD4—Kawasaki disease	1.89e-05	0.00166	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—VEGFA—Kawasaki disease	1.85e-05	0.00163	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD4—Kawasaki disease	1.78e-05	0.00157	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD4—Kawasaki disease	1.71e-05	0.00151	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CRP—Kawasaki disease	1.69e-05	0.00149	CbGpPWpGaD
Mesalazine—CHUK—Disease—CCR5—Kawasaki disease	1.68e-05	0.00148	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CRP—Kawasaki disease	1.54e-05	0.00135	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCR5—Kawasaki disease	1.18e-05	0.00104	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD4—Kawasaki disease	1.14e-05	0.00101	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR5—Kawasaki disease	1.07e-05	0.000941	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD4—Kawasaki disease	1.06e-05	0.000931	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD4—Kawasaki disease	1.04e-05	0.000914	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CCR5—Kawasaki disease	9.96e-06	0.000878	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MMP9—Kawasaki disease	6.44e-06	0.000568	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD4—Kawasaki disease	6.26e-06	0.000551	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MMP9—Kawasaki disease	5.84e-06	0.000515	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—VEGFA—Kawasaki disease	5.78e-06	0.00051	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—VEGFA—Kawasaki disease	5.24e-06	0.000462	CbGpPWpGaD
